Drug Trial Radar · NCT06649110
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Last checked: Nov 20, 2026Latest source record: Jul 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
232
Planned (sponsor's estimate)
Start
Oct 24, 2024
Primary completion
Nov 29, 2028
Study completion Dec 31, 2028
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Oct 18, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A study to learn about the treatment LTP001 in healthy participants (Part A) and in participants with PAH (Part B)
Conditions
- Healthy Volunteers, Pulmonary Arterial Hypertension
Interventions
LTPDrug
LTP001
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part A- Number of participants with Adverse events (AEs) and Serious Adverse events (SAEs)Time frame: Baseline to Day 35
- Part B-Treatment Period 1: Change in pulmonary vascular resistance (PVR)Time frame: Baseline to Week 24
- Part B-Treatment Period 2: Number of participants with Adverse events (AEs) and Serious Adverse events (SAEs)Time frame: From Day 1 until Week 106
Locations
87 sites in 18 countries. Site status is shown where the registry gives one.
Arizona Pulmonary Specialists Ltd
Scottsdale, Arizona · Recruiting
UC Irvine Medical Center
Orange, California · Recruiting
Stanford Medical Center
Stanford, California · Recruiting
Univ Colorado Hospital
Aurora, Colorado · Recruiting
Central Florida Pulmonary Group
Orlando, Florida · Recruiting
University of South Florida
Tampa, Florida · Recruiting
Emory University School of Medicine
Atlanta, Georgia · Recruiting
U of Kansas Medical Center
Kansas City, Kansas · Recruiting
Norton Infectious Diseases Specialists
Louisville, Kentucky · Recruiting
Tufts Medical Center
Boston, Massachusetts · Recruiting
Lahey Hospital and Medical Center
Burlington, Massachusetts · Recruiting
Sky Integrative Medical Center SKYCRNG PPDS
Ridgeland, Mississippi · Recruiting
Summit Health Eastside Clinic
Bend, Oregon · Recruiting
Allegheny General Hospital
Pittsburgh, Pennsylvania · Recruiting
Statcare Pulmonary Consultants
Knoxville, Tennessee · Recruiting
PPD Development LP
Austin, Texas · Recruiting
PPD Development LP
Austin, Texas · Recruiting
UT Southwestern Medical Center
Dallas, Texas · Recruiting
The University of Utah
Salt Lake City, Utah · Recruiting
Pul Ass Richmond Inc P A R
Richmond, Virginia · Recruiting
Novartis Investigative Site
CABA, Argentina · Recruiting
Novartis Investigative Site
Río Cuarto, Argentina · Recruiting
Novartis Investigative Site
San Miguel de Tucumán, Argentina · Recruiting
Novartis Investigative Site
Santa Fe, Argentina · Recruiting
Novartis Investigative Site
Buenos Aires, Buenos Aires F.D., Argentina · Recruiting
Novartis Investigative Site
Camperdown, New South Wales, Australia · Recruiting
Novartis Investigative Site
Darlinghurst, New South Wales, Australia · Recruiting
Novartis Investigative Site
New Lambton Heights, New South Wales, Australia · Recruiting
Novartis Investigative Site
Adelaide, South Australia, Australia · Recruiting
Novartis Investigative Site
Leuven, Vlaams Brabant, Belgium · Recruiting
Novartis Investigative Site
Porto Alegre, Rio Grande do Sul, Brazil · Recruiting
Novartis Investigative Site
Prague, Czechia · Recruiting
Novartis Investigative Site
Prague, Czechia · Recruiting
Novartis Investigative Site
Brest, France · Recruiting
Novartis Investigative Site
Clamart, France · Recruiting
Novartis Investigative Site
Grenoble, France · Recruiting
Novartis Investigative Site
Montpellier, France · Recruiting
Novartis Investigative Site
Nice, France · Recruiting
Novartis Investigative Site
Pessac, France · Recruiting
Novartis Investigative Site
Poitiers, France · Recruiting
Showing 40 of 87 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.